Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

What To Watch For In 1st Paragard Bellwether Trial No Photo Available

Cara Salvatore

Drugmaker Teva is set to face its first bellwether trial starting Tuesday in a multidistrict litigation containing thousands of claims... (more story)

Immigrant Visa Pause Could Test Limits Of Executive Power No Photo Available

Britain Eakin

The Trump administration's indefinite pause on immigrant visas for applicants from 75 countries may test the outer bounds of executive... (more story)

Dispatch From JPM: Fewer Health Deals Don't Dampen Mood No Photo Available

Yeji Jesse Lee

Despite an unusual dearth of big deal announcements, attorneys at the annual J.P. Morgan healthcare conference in San Francisco are st... (more story)